199 related articles for article (PubMed ID: 34735632)
1. Comparison of iodine-125 plaque brachytherapy and gamma knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients.
Guleser UY; Sarici AM; Ucar D; Gonen B; Sengul Samanci N; Özgüroğlu M
Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1337-1343. PubMed ID: 34735632
[TBL] [Abstract][Full Text] [Related]
2. Gamma-knife-based stereotactic radiosurgery for medium- and large-sized posterior uveal melanoma.
Sarici AM; Pazarli H
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):285-94. PubMed ID: 22944897
[TBL] [Abstract][Full Text] [Related]
3. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
4. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
Puusaari I; Damato B; Kivelä T
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience.
Mazzini C; Pieretti G; Vicini G; Nicolosi C; Scoccianti S; Pertici M; Greto D; Desideri I; Bordi L; Pecchioli G; Virgili G
Melanoma Res; 2021 Feb; 31(1):38-48. PubMed ID: 32826711
[TBL] [Abstract][Full Text] [Related]
7. Microinvasive tumor endoresection in combination with ocular stereotactic radiosurgery.
Sinyavskiy OA; Troyanovsky RL; Ivanov PI; Golovin AS; Tibilov AV; Solonina SN; Astapenko AM; Zubatkina IS
J Neurosurg; 2016 Dec; 125(Suppl 1):58-63. PubMed ID: 27903184
[TBL] [Abstract][Full Text] [Related]
8. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
9. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
10. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
11. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
12. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA
Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456
[TBL] [Abstract][Full Text] [Related]
13. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
[TBL] [Abstract][Full Text] [Related]
15. Retrospective Analysis of Radiation-Induced Complications of Uveal Melanoma Patients Treated With Brachytherapy in the Era of Anti-VEGF.
Hasegawa N; Teh BS; Tran K; Ivey F; Olek D; Pino R; Chuang AZ; Bretana ME; Butler EB; Schefler AC
Am J Ophthalmol; 2024 Apr; 260():49-59. PubMed ID: 38081570
[TBL] [Abstract][Full Text] [Related]
16. Therapy of uveal melanoma A Review.
Rusňák Š; Hecová L; Kasl Z; Sobotová M; Hauer L
Cesk Slov Oftalmol; 2020; 77(1):1-13. PubMed ID: 33086849
[TBL] [Abstract][Full Text] [Related]
17. Complications in patients with uveal melanoma after stereotactic radiosurgery and brachytherapy.
Furdova A; Strmen P; Sramka M
Bratisl Lek Listy; 2005; 106(12):401-6. PubMed ID: 16642665
[TBL] [Abstract][Full Text] [Related]
18. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
19. Early Results of Stereotactic Radiosurgery in Uveal Melanoma and Risk Factors for Radiation Retinopathy.
Özcan G; Gündüz AK; Mirzayev İ; Oysul K; Uysal H
Turk J Ophthalmol; 2020 Jun; 50(3):156-162. PubMed ID: 32631003
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric and radiobiologic comparison of
Gorovets D; Gagne NL; Melhus CS
Brachytherapy; 2017; 16(2):433-443. PubMed ID: 28161431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
